As of 2026-04-02, the Fair Value of Elevation Oncology Inc (ELEV) is -4.05 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.37 USD, the upside of Elevation Oncology Inc is -1,209.51%.
With the market price of 0.37 USD and our fair value calculation, Elevation Oncology Inc (ELEV) is not a good investment. Investing in ELEV stocks now will result in a potential loss of 1,209.51%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -17.27 | -32.04 | -95.08 | -45.70 | -44.49 | -46.92 |
| YoY growth | -193.71% | -85.52% | -196.75% | 51.93% | 2.67% | -84.28% |
| Market Cap (mil) | 21.63 |
| P/E | |
| Forward P/E |
| EPS | -0.81 |
| Avg earnings growth rate | -84.28% |
| TTM earnings | -47.99 |